| Dr Stewart E Wiegand, MD | |
|
755 Mt Vernon Highway, Suite 110, Atlanta, GA 30328-4276 | |
| (404) 256-9692 | |
| (404) 256-9404 |
| Full Name | Dr Stewart E Wiegand |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Location | 755 Mt Vernon Highway, Atlanta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477544138 | NPI | - | NPPES |
| CM5399 | Other | GA | RAILROAD MEDICARE |
| 00176481C | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 012988 (Georgia) | Primary |
| Entity Name | Northside Dermatology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508047846 PECOS PAC ID: 6608857677 Enrollment ID: O20040526000366 |
News Archive
The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.
Researchers in the UK have developed a prognostic tool that accurately predicts whether patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent causes coronavirus disease 2019 (COVID-19) – will require admission to the intensive care unit (ICU), die, or survive without escalation to ICU.
Feelings of anxiety very effectively prevent people from getting into situations that are too dangerous. Those who have had a terrible experience initially tend to avoid the place of tragedy out of fear. If no other oppressive situation arises, normally the symptoms of fear gradually subside.
Identification of genetic variations in the genes coding for the hormone FSH may provide new treatments for male and female infertility, according to work presented at the European Congress of Endocrinology in Copenhagen.
Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stewart E Wiegand, MD 401 S Main St, Suite A2, Alpharetta, GA 30009-1974 Ph: (404) 256-9692 | Dr Stewart E Wiegand, MD 755 Mt Vernon Highway, Suite 110, Atlanta, GA 30328-4276 Ph: (404) 256-9692 |
News Archive
The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.
Researchers in the UK have developed a prognostic tool that accurately predicts whether patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent causes coronavirus disease 2019 (COVID-19) – will require admission to the intensive care unit (ICU), die, or survive without escalation to ICU.
Feelings of anxiety very effectively prevent people from getting into situations that are too dangerous. Those who have had a terrible experience initially tend to avoid the place of tragedy out of fear. If no other oppressive situation arises, normally the symptoms of fear gradually subside.
Identification of genetic variations in the genes coding for the hormone FSH may provide new treatments for male and female infertility, according to work presented at the European Congress of Endocrinology in Copenhagen.
Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.
› Verified 3 days ago
Dr. Alvin R Solomon, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1365 Clifton Rd Ne, Department Of Dermatology, Atlanta, GA 30322 Phone: 404-727-3669 Fax: 404-727-5878 | |
Howa Yeung, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1525 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-778-3333 | |
Dr. Diamondis John Papadopoulos, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 875 Johnson Ferry Rd Ne, Ste 300, Atlanta, GA 30342 Phone: 404-257-9933 Fax: 404-257-9931 | |
Dr. Adar Berghoff, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 875 Johnson Ferry Rd, Suite 300, Atlanta, GA 30342 Phone: 404-257-9933 Fax: 404-257-9931 | |
Dr. Shenara Austin Sexton, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5505 Peachtree Dunwoody Rd Ste 412, Atlanta, GA 30342 Phone: 404-459-9177 Fax: 404-389-0400 | |
Dr. Seema Panduranga Kini, MD, MS Dermatology Medicare: Accepting Medicare Assignments Practice Location: Emory University Graduate, 1648 Pierce Dr., Atlanta, GA 30322 Phone: 404-778-0263 | |
Dr. Kelli Ingram Baender, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3379 Peachtree Rd. Ne, Suite 500, Atlanta, GA 30326 Phone: 404-355-5484 Fax: 404-355-5787 |